Changes in IL-6, YKL40 and VEGF during adalimumab treatment in patients with active rheumatoid arthritis

L.S. Knudsen, J.S. Johansen, U.M. Dohn, M.L. Hetland, A. Boonen, M.S. Hansen, A. Hansen, Ole Rintek Madsen, M. Hasselquist, J.M. Moller, M. Ostergaard

Abstract

Udgivelsesdato: 2008/9
Original languageEnglish
JournalArthritis & Rheumatism
Volume58
Issue number9 Suppl. S.
Pages (from-to)S552-S553
ISSN0004-3591
Publication statusPublished - 2008

Cite this